Skip to content
The Longevity Archive
Dasatinib in all countries

Legal status · Australia

Is Dasatinib legal in Australia?

Approved medicineLongevityEvidence: Preliminary

Yes. Dasatinib is an approved medicine in Australia, classified as "TGA-registered (for its labeled use), prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.

Dasatinib in Australia at a glance

ClassificationTGA-registered (for its labeled use), prescription only
TGA approval statusApproved by TGA for its labeled use
Evidence levelPreliminary (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the Dasatinib profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

  • 01

    TGA has approved Dasatinib for at least one labeled indication, so a pharmaceutical-grade product exists in Australia and is dispensed on prescription.

  • 02

    Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.

  • 03

    Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.

What Dasatinib is

An FDA-approved leukemia drug repurposed in research as a senolytic, most often combined with quercetin to clear senescent cells.

Dasatinib is a kinase inhibitor approved as Sprycel for certain leukemias. In longevity research it is repurposed as a senolytic, clearing senescent cells, and is studied in the 'D+Q' combination with quercetin for conditions linked to cellular aging such as diabetic kidney disease and lung fibrosis.

Mechanism: Inhibits survival signaling in senescent cells, triggering their death, especially alongside quercetin.

Regulatory history: FDA-approved for leukemia; senolytic use is off-label and investigational

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Dasatinib at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Dasatinib in other countries

Frequently asked questions

Is Dasatinib legal in Australia?

Yes. Dasatinib is an approved medicine in Australia, classified as "TGA-registered (for its labeled use), prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.

Can I buy Dasatinib in Australia?

Only with a prescription. Dasatinib is classified as "TGA-registered (for its labeled use), prescription only" in Australia, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.

Is Dasatinib TGA approved?

Yes, for its labeled indication. In Australia Dasatinib is classified as "TGA-registered (for its labeled use), prescription only". For comparison, the US FDA status is: FDA-approved for leukemia; senolytic use is off-label and investigational. Evidence level: Preliminary.

Related compounds in Australia

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Dasatinib live on its compound profile.

Dasatinib profile

This page is general information about the regulatory status of Dasatinib in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.